A New Orally Active, Aminothiol Radioprotector-Free of Nausea and Hypotension Side Effects at Its Highest Radioprotective Doses

Mar 22

Written By Obvia

Soref C, Hacker T, Fahl WE.

International Journal of Radiation Oncology, Biology, Physics 82(5):e701-7, February 2012; DOI:10.1016/j.ijrobp.2011.11.038

Synthesis and Growth Regulatory Activity of a Prototype Member of a New Family of Aminothiol Radioprotectors

ROS-Scavenger and Radioprotective Efficacy of the New PrC-210 Aminothiol